-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the "Regulations for the Classification of Prescription Drugs and Over-the-Counter Drugs (Trial)" (formerly Order No.
The relevant drug marketing authorization holders are requested to submit a supplementary application for the revision of the drug label in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations, and report to the provincial drug regulatory authority for the record, and promptly notify the revised content of the label Relevant medical institutions, pharmaceutical business enterprises and other units
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents
Hereby announce
Attachment: 1.
2.
State Food and Drug Administration
December 9, 2020
Announcement No.
Announcement No.